openalexFrontiers in Pharmacology2026-07-24
Indobufen-based dual antiplatelet therapy in patients undergoing PCI: a systematic review and meta-analysis
Yiheng Liu, B Y Liu, Weiran Dai
Background Conventional dual antiplatelet therapy (DAPT) post percutaneous coronary intervention (PCI) comprises aspirin and a P2Y 12 inhibitor. However, aspirin increases gastrointestinal and bleeding risks. Indobufen, a reversible COX-1 inhibitor, may offer a safer alternative.…